These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 50762

  • 1. Tyrosinase activity in three types of the malignant melanoma: superficial spreading melanoma, lentigo maligna melanoma and nodular melanoma.
    Haensch R.
    Arch Dermatol Forsch; 1975; 252(3):193-201. PubMed ID: 50762
    [Abstract] [Full Text] [Related]

  • 2. Tyrosinase activity in dermal nevus cells.
    Thorne EG, Mottaz JH, Zelickson AS.
    Arch Dermatol; 1971 Dec; 104(6):619-24. PubMed ID: 4117664
    [No Abstract] [Full Text] [Related]

  • 3. Involvement of tyrosinase in melanin formation in murine melanoma.
    Hearing VJ, Ekel TM.
    J Invest Dermatol; 1975 Feb; 64(2):80-5. PubMed ID: 804529
    [Abstract] [Full Text] [Related]

  • 4. Generalized melanosis secondary to malignant melanoma. Report of a case with serum and tissue tyrosinase studies.
    Sohn N, Gang H, Gumport SL, Goldstein M, Deppisch LM.
    Cancer; 1969 Nov; 24(5):897-903. PubMed ID: 4982120
    [No Abstract] [Full Text] [Related]

  • 5. Histochemical findings in different types of malignant melanoma: biological and clinical significance.
    Paul E.
    Arch Dermatol Res (1975); 1975 Dec 10; 254(2):159-74. PubMed ID: 814858
    [Abstract] [Full Text] [Related]

  • 6. [Tyrosinases of nevo-cellular nevi and human malignant malanomas].
    Voulot C, Ortonne JP.
    Ann Dermatol Syphiligr (Paris); 1975 Dec 10; 102(5-6):547-51. PubMed ID: 821383
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Patterns of staining for neurone specific enolase in benign and malignant melanocytic lesions of the skin.
    Dhillon AP, Rode J.
    Diagn Histopathol; 1982 Dec 10; 5(3):169-74. PubMed ID: 6183082
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of tyrosinase activity in mouse melanoma and skin by changes in melanosomal membrane permeability.
    Van Woert MH, Korb F, Prasad KN.
    J Invest Dermatol; 1971 May 10; 56(5):343-8. PubMed ID: 4997370
    [No Abstract] [Full Text] [Related]

  • 15. Biological behaviour of cutaneous malignant melanomas.
    Søndergaard K.
    Pathology; 1985 Apr 10; 17(2):255-7. PubMed ID: 4047727
    [Abstract] [Full Text] [Related]

  • 16. [The effect of dinitrophenylation on the tyrosinase activity of extracts from human melanomas].
    Schwartze G.
    Dermatol Monatsschr; 1986 Apr 10; 172(8):498-500. PubMed ID: 3095156
    [No Abstract] [Full Text] [Related]

  • 17. [Ultrastructural studies of the occurrence of tyrosinase in transplantable amelanotic melanoma in Syrian hamster].
    Bomirski A, Wrzolkowa T.
    Przegl Dermatol; 1976 Apr 10; 63(1):11-8. PubMed ID: 815964
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lentigo maligna and malignant melanoma.
    Jackson R, Williamson GS, Beattie WG.
    Can Med Assoc J; 1966 Oct 22; 95(17):846-51. PubMed ID: 5922502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.